CLINICAL_TRIALS
trial_result
· 2021-03-19
Clinical Trial Update: Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients [Phase 4]
Summary
Phase 4 trial assessing delirium prevention with ketamine in ENT cancer patients was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Otolaryngeal Cancer | Phase 4 | Status: TERMINATED | Results posted: 2021-03-19